Connection
Melanie Everitt to Immunosuppressive Agents
This is a "connection" page, showing publications Melanie Everitt has written about Immunosuppressive Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.384 |
|
|
|
-
Wolfe KR, Kelly SL, Steinberg E, Pliego J, Everitt MD. Predictors of neuropsychological functioning and medication adherence in pediatric heart transplant recipients referred for neuropsychological evaluation. Pediatr Transplant. 2020 02; 24(1):e13615.
Score: 0.127
-
Heble A, Everitt MD, Gralla J, Miyamoto SD, Lahart M, Eshelman J. Safety of mTOR inhibitor continuation in pediatric heart transplant recipients undergoing surgical procedures. Pediatr Transplant. 2018 02; 22(1).
Score: 0.111
-
Castleberry C, Ziniel S, Almond C, Auerbach S, Hollander SA, Lal AK, Fenton M, Pahl E, Rossano JW, Everitt MD, Daly KP. Clinical practice patterns are relatively uniform between pediatric heart transplant centers: A survey-based assessment. Pediatr Transplant. 2017 Aug; 21(5).
Score: 0.108
-
Chen TT, Greene MM, Everitt MD, Simpson KE. Basiliximab as maintenance immunosuppression in heart transplant recipients: A single pediatric center experience. Pediatr Transplant. 2023 03; 27(2):e14438.
Score: 0.039